UK start-up Autolus starts 'living medicine' cancer trials

Autolus, a UCL spin-out company, has launched clinical trials as part of its plans to develop 'living medicine' cancer therapies which genetically engineer the patient's own immune cells to fight cancer. Read: Financial Times (£)